Kevin Brodbeck
Chief Tech/Sci/R&D Officer chez DECIPHERA PHARMACEUTICALS, INC.
Profil
Kevin Brodbeck is currently the Chief Technical Officer & Senior Vice President at Deciphera Pharmaceuticals, Inc. He previously worked as the Director-Product Development at ALZA Corp.
from 1993 to 1999 and as the Head-Formulation & Process Sciences at Powderject Technologies, Inc. from 1999 to 2002.
He also held the position of Senior Vice President-Technical Operations at Nektar Therapeutics.
Brodbeck received his undergraduate degree from the University of California, Berkeley and his graduate and doctorate degrees from the University of Illinois.
Postes actifs de Kevin Brodbeck
| Sociétés | Poste | Début |
|---|---|---|
| DECIPHERA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/01/2023 |
Anciens postes connus de Kevin Brodbeck
| Sociétés | Poste | Fin |
|---|---|---|
| Powderject Technologies, Inc. | Corporate Officer/Principal | 01/01/2002 |
| ALZA CORPORATION | Corporate Officer/Principal | 01/11/1999 |
| NEKTAR THERAPEUTICS | Chief Tech/Sci/R&D Officer | - |
Formation de Kevin Brodbeck
| University of California, Berkeley | Undergraduate Degree |
| University of Illinois | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| NEKTAR THERAPEUTICS | Health Technology |
| DECIPHERA PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
ALZA Corp.
 ALZA Corp. Pharmaceuticals: MajorHealth Technology ALZA Corp. provides drug delivery solutions and develops pharmaceutical products. The company applies its delivery technologies to develop pharmaceutical products with enhanced therapeutic value for its own portfolio and for many of the world's leading pharmaceutical companies. The company was founded by Martin Gerstel and Alejandro Zaffaroni in 1968 and is headquartered in Vacaville, CA. | Health Technology |
| Powderject Technologies, Inc. |
